Katholische Hospitalvereinigung Thueringen gGmbH — Clinical Trial Site

8 Registered trials

3 Currently recruiting

Organisation

Katholische Hospitalvereinigung Thueringen gGmbH

Location

Erfurt, Germany

Identifier

ORG-100025976

Address

Haarbergstraße 72, Melchendorf, 99097, Germany

Departments

2320: Kath. Krankenhaus "St. Johann Nepomuk" Erfurt, Klinik fur lnnere Medizin I1/Kardiologie
Kath. Hospitalvereinigung Thüringen gGmbH - KKH St. Johann Nepomuk - Innere Med. II
Kath.Krankenhaus St. Johann Nepomuk, Kl.f.inneremed. II/ Kardiologie u.InternistischeIntensivmedizin
Klinik für Innere Medizin II
Klinik für Innere Medizin II /Kardiologie und Internistische Intensivmedizin
Klinik für Innere Medizin II/ Kardiologie
Klinik für Innere Medizin II/Kardiologie
Klinik für Innere Medizin ll / Kardiologie und Internistische Intensivmedizin Intensivmedizin

Clinical trials at this site (8)

Search interface

HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08
A Placebo-Controlled Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease … Ended

2023-507795-51-00 atherosclerotic heart and blood vessel disease (the nar 5 2022-05-17
A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering … Ended

2024-511076-32-00 Hypercholesterolemia 6 2024-06-21
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
Study to understand if inclisiran is better than a placebo at lowering LDL-cholesterol,is safe and can have an impact on patient quality of … Ended

2024-511263-28-00 Hypercholesterolemia 6 2022-04-08
A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Ended

2022-500881-80-00 Chronic Heart Failure With Reduced Ejection Fraction 5 2021-10-29